We are focused on developing medicines that make a difference. Together with you, we can help change respiratory patients’ lives for the better.

Inspired to deliver value

Saving the NHS money is a key driver for all we do. We ensure we deliver value, via robust and responsive supply chains.

Inspired to help save lives

Despite advances in respiratory medicine, a lot remains to be done to help those with asthma and COPD. In England and Wales, asthma deaths increased by a third over the past decade, and COPD is one of the three leading contributors to respiratory mortality in the UK as whole.1,2 It will take all the respiratory community working together to change this and we are committed to help drive this forward.

Be inspired!


References: 1. Iacobucci G. BMJ 2019;366:doi: https://doi.org/10.1136/bmj.l5108. 2. Asthma + Lung UK website. Chronic obstructive pulmonary disease (COPD) statistics. Available at: https://statistics.blf.org.uk/copd. Accessed February 2024.

This page leads to information about Glenmark Respiratory and is for healthcare professionals only. If you are a member of the public, click on the orange labelled button below where you will find more information on respiratory conditions.

Please click on one of the buttons below.

I am a
healthcare
professional
I am NOT a
healthcare
professional
Adverse events should be reported.
If you would like to report an adverse event (medication side effect), please click here
© 2024 Glenmark Pharmaceuticals Europe Ltd.
 All rights reserved.
Job code: PP-UK-GPL-0002 V6
 Date of preparation: May 2024